Can low-dose CT perfusion imaging accurately assess response of advanced gastric cancer with neoadjuvant chemotherapy?

about

Can low-dose CT perfusion imaging accurately assess response of advanced gastric cancer with neoadjuvant chemotherapy?

Item

http://www.wikidata.org/entity/Q51828946

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Can low-dose CT perfusion imag ...... with neoadjuvant chemotherapy?

@en

Can low-dose CT perfusion imag ...... with neoadjuvant chemotherapy?

@nl

type

Item

label

Can low-dose CT perfusion imag ...... with neoadjuvant chemotherapy?

@en

Can low-dose CT perfusion imag ...... with neoadjuvant chemotherapy?

@nl

prefLabel

Can low-dose CT perfusion imag ...... with neoadjuvant chemotherapy?

@en

Can low-dose CT perfusion imag ...... with neoadjuvant chemotherapy?

@nl

P1476

Can low-dose CT perfusion imag ...... with neoadjuvant chemotherapy?

@en

P2093

Gen Yan

http://www.w3.org/2001/XMLSchema#string

Jie Li

http://www.w3.org/2001/XMLSchema#string

Lin-Fang Jin

http://www.w3.org/2001/XMLSchema#string

Peng Zhao

http://www.w3.org/2001/XMLSchema#string

Yu-Xi Ge

http://www.w3.org/2001/XMLSchema#string

Zhi-Hui Xie

http://www.w3.org/2001/XMLSchema#string

Zong-Qiong Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical practice guidelines for gastric cancer in Korea: an evidence-based approach

Phase II study of sunitinib as second-line treatment for advanced gastric cancer.

Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.

Computed tomography (CT) perfusion as an early predictive marker for treatment response to neoadjuvant chemotherapy in gastroesophageal junction cancer and gastric cancer--a prospective study.

Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma.

Neoadjuvant chemotherapy for gastric cancer in Japan: a standing position by comparing with adjuvant chemotherapy.

Staging and evaluation of neoadjuvant chemotherapy response with ¹⁸F-FDG PET/CT in NUT-midline carcinoma in a child: a case report and review of the literature.

Role of CT perfusion imaging in patients with variously differentiated gastric adenocarcinoma.

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

Neoadjuvant chemotherapy for gastric cancer: what are we trying to accomplish?

P304

981-991

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/XST-17271

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28697579

http://www.w3.org/2001/XMLSchema#string